Vaxxinity Inc Net Income per Employee (VAXX), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Vaxxinity Inc   (NASDAQ: VAXX)
 

Vaxxinity Inc Net Income per Employee

VAXX's Quarterly Results, Trends, Rankings, Statistics
Vaxxinity Inc recorded a cumulative net loss of $-57 million during 12 month ending in the fourth quarter 2023.
The Healthcare sector has seen employees of 328 other companies achieving higher income per employee. While Vaxxinity Inc 's total ranking has deteriorated compared to the previous quarter from 4346 to 4761.


What is Income per Employee Ratio?






VAXX Net Income per Employee (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -1,054,352 -1,222,185 -1,335,278 -1,395,926 -1,393,000
VAXX's Total Ranking # 4761 # 4346 # 4430 # 4505 # 5096
Seq. Net Income Change - - - - -


VAXX Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 329
Healthcare Sector # 790
Overall Market # 4761

Net Income per Employee Statistics
High Average Low
$ -562,759 $ -1,644,148 $ -3,197,963
(Sep 30 2021)   (Jun 30 2022)







Companies with similar Income per Employee for 12 month ending Dec 31 2023, within Healthcare Sector Income per Employee Income 12 month ending Dec 31 2023Number of Employees Dec 31 2023


Date modified: 2026-09-08T15:11:13+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.